Author： Gerra G. Maremmani I. Capovani B. Somaini L. Berterame S. Tomas-Rossello J. Saenz E. Busse A. Kleber H.
Publisher： Informa Healthcare
ISSN： 1082-6084
Source： Substance Use & Misuse, Vol.44, Iss.5, 2009-04, pp. : 663-671
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Long-Acting -Agonists in the Treatment of Acute Exacerbations of COPD
By Cazzola M.
Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. :
Access to resources
Recommend
Safe use of long-acting β-agonists: what have we learnt?
Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. :
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. :
Long-acting -agonists not linked to increased respiratory deaths
Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. :